Literature DB >> 4561511

Neuronal monoamine oxidase: specific enzyme types and their rates of formation.

N H Neff, C Goridis.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4561511

Source DB:  PubMed          Journal:  Adv Biochem Psychopharmacol        ISSN: 0065-2229


× No keyword cloud information.
  18 in total

1.  Monoamine oxidase activity in different density gradient fractions of human platelets.

Authors:  D L Murphy; J L Costa; B Shafer; L Corash
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.

Authors:  M B Youdim; A Gross; J P Finberg
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes.

Authors:  M D Houslay; K F Tipton
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

Review 4.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

5.  Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.

Authors:  P C Waldmeier; A Delini-Stula; L Maître
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

6.  Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.

Authors:  P C Waldmeier; L Maître
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-08       Impact factor: 3.000

7.  Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.

Authors:  J P Finberg; M Tenne
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

8.  Pre- and post-partum plasma amine oxidase differences in the rhesus monkey (Macaca mulatta).

Authors:  D E Redmond; J Baulu; D L Murphy
Journal:  Experientia       Date:  1976-09-15

9.  Molecular biology of neurological and psychiatric disorders. I. Effect of parkinsonism, age, sex and L-dopa on platelet monoamine oxidase.

Authors:  E A Zeller; B Boshes; J Arbit; M Bieber; E R Blonsky; M Dolkart; S V Huprikar
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

10.  Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.

Authors:  J P Finberg; M Tenne; M B Youdim
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.